Execution of divestment in pharmaceutical industry

Project leader role in the global manufacturing deal team – executing the divestment / separation

Company:
Takeda Pharmaceuticals International AG, Switzerland – via provider

Role:
Project leader role in the global manufacturing deal team – executing the divestment / separation

Industry:
Pharmaceuticals

Revenue:
approx. 25 Bn. € (2021)

Employees:
Global 47.000

Timeline:
09/2020 – 05/2021

Situation:
Execution of a divestiture

Location:
Tokyo, Japan

Internet:
www.takeda.com

Responsibility:

  • Project lead for the workstreams Master Data and Serialization 
  • Responsible for overarching supply chain topics

Context:

  • Prepare and execute the handover of approx. 110 medical products and 2 manufacturing sites

Actions:

  • Align master data requirements between buyer and seller, including legal clearance
  • Secure collection and verification of data (sender side), data transfer and official close out
  • Create and align road map for serialization handover of manufacturing sites (first time business case) between seller and buyer
  • Align road map between buyer and seller
  • Integration of new data flows in existing / new IT-systems, including functional testing and process validation
  • Development and implementation of an advanced shipping notification as well as cross-company release procedures for finished product

Result:

  • Handover to buyer carried out according to schedule
  • All data transfers completed on time
  • Serialization operable in new set as planned as of week 3 after hand-over

Special Challenges:

  • Fully virtual team, no personal interaction
  • Timeline depending on multiple antitrust clearances
Scroll to Top